Introduction to cancer genetic susceptibility syndromes
Authors:
- 2 December 2016
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2016 (1) , 293-301
Abstract
The last 30 years have witnessed tremendous advances in our understanding of the cancer genetic susceptibility syndromes, including those that predispose to hematopoietic malignancies. The identification and characterization of families affected by these syndromes is enhancing our knowledge of the oncologic and nononcologic manifestations associated with predisposing germ line mutations and providing insights into the underlying disease mechanisms. Here, we provide an overview of the cancer genetic susceptibility syndromes, focusing on aspects relevant to the evaluation of patients with leukemia and lymphoma. Guidance is provided to facilitate recognition of these syndromes by hematologists/oncologists, including descriptions of the family history features, tumor genotype, and physical or developmental findings that should raise concern for an underlying cancer genetic syndrome. The clinical implications and management challenges associated with cancer susceptibility syndromes are also discussed.Keywords
This publication has 40 references indexed in Scilit:
- Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAJAMA Oncology, 2016
- Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy‐related leukemiaCancer, 2015
- Predisposition to Pediatric and Hematologic Cancers: A Moving TargetAmerican Society of Clinical Oncology Educational Book, 2014
- Mutational landscape and significance across 12 major cancer typesNature, 2013
- Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasmsJournal of Medical Genetics, 2012
- Genetics, genomics, and cancer risk assessmentCA: A Cancer Journal for Clinicians, 2011
- Unexpected findings in cancer predisposition genes detected by array comparative genomic hybridisation: what are the issues?Journal of Medical Genetics, 2011
- Mutation ofCEBPAin Familial Acute Myeloid LeukemiaNew England Journal of Medicine, 2004
- Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaNature Genetics, 1999
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971